Anyone can get pneumococcal pneumonia.
You may be at increased risk if you are:
19 or older with certain chronic conditions
Conditions include asthma, diabetes,
COPD, or chronic heart disease.
Adults taking certain medicines that
suppress the immune system are also
at increased risk.
Learn more about
condition-related risk
IMPORTANT SAFETY INFORMATION AND INDICATION
PREVNAR 20TM
(Pneumococcal 20-valent Conjugate Vaccine)
IMPORTANT SAFETY INFORMATION
-
Prevnar 20 should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid
- Adults with weakened immune systems may have a lower response to Prevnar 20. Safety data are not available for these groups. Your healthcare provider can tell you if Prevnar 20 is right for you
- In adults 18 years of age and older, the most common side effects (>10%) were pain at the injection site, muscle pain, fatigue, headache, and joint pain. Additionally, injection site swelling was also common in adults 18 through 59 years of age
- Ask your healthcare provider about the risks and benefits of Prevnar 20. Only a healthcare provider can decide if Prevnar 20 is right for you
Please click here for Prevnar 20 Full Prescribing Information.
INDICATION FOR PREVNAR 20
- Prevnar 20 is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in adults 18 years of age and older
- The indication for preventing pneumonia caused by S. pneumoniae serotypes 8, 10A, 11A, 12F, 15B, 22F, and 33F is approved based on immune responses. Continued approval may depend on a supportive study
IMPORTANT SAFETY INFORMATION AND INDICATION
PREVNAR 13Ⓡ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])
IMPORTANT SAFETY INFORMATION
- Prevnar 13Ⓡ should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13Ⓡ or any diphtheria toxoid–containing vaccine
- Adults with weakened immune systems (eg, HIV infection, leukemia) may have a reduced immune response
- In adults, the most common side effects (>5%) were pain, redness, and swelling at the injection site, limitation of arm movement, fatigue, headache, muscle pain, joint pain, decreased appetite, vomiting, fever, chills, and rash
- Ask your healthcare provider about the risks and benefits of Prevnar 13Ⓡ. Only a healthcare provider can decide if Prevnar 13Ⓡ is right for you
Please click here for Prevnar 13Ⓡ Full Prescribing Information.
INDICATIONS FOR PREVNAR 13Ⓡ
- Prevnar 13Ⓡ is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F)
- Prevnar 13Ⓡ is not 100% effective and will only help protect against the 13 strains included in the vaccine
Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1‐800‐822‐7967.
IMPORTANT SAFETY INFORMATION AND INDICATION
PREVNAR 20TM
(Pneumococcal 20-valent Conjugate Vaccine)
IMPORTANT SAFETY INFORMATION
- Prevnar 20 should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid
- Adults with weakened immune systems may have a lower response to Prevnar 20. Safety data are not available for these groups. Your healthcare provider can tell you if Prevnar 20 is right for you
- In adults 18 years of age and older, the most common side effects (>10%) were pain at the injection site, muscle pain, fatigue, headache, and joint pain. Additionally, injection site swelling was also common in adults 18 through 59 years of age
- Ask your healthcare provider about the risks and benefits of Prevnar 20. Only a healthcare provider can decide if Prevnar 20 is right for you
Please click here for Prevnar 20 Full Prescribing Information.
INDICATION FOR PREVNAR 20
- Prevnar 20 is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in adults 18 years of age and older
- The indication for preventing pneumonia caused by S. pneumoniae serotypes 8, 10A, 11A, 12F, 15B, 22F, and 33F is approved based on immune responses. Continued approval may depend on a supportive study
PREVNAR 13Ⓡ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])
IMPORTANT SAFETY INFORMATION
- Prevnar 13Ⓡ should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13Ⓡ or any diphtheria toxoid–containing vaccine
- Adults with weakened immune systems (eg, HIV infection, leukemia) may have a reduced immune response
- In adults, the most common side effects (>5%) were pain, redness, and swelling at the injection site, limitation of arm movement, fatigue, headache, muscle pain, joint pain, decreased appetite, vomiting, fever, chills, and rash
- Ask your healthcare provider about the risks and benefits of Prevnar 13Ⓡ. Only a healthcare provider can decide if Prevnar 13Ⓡ is right for you
Please click here for Prevnar 13Ⓡ Full Prescribing Information.
INDICATIONS FOR PREVNAR 13Ⓡ
- Prevnar 13Ⓡ is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F)
- Prevnar 13Ⓡ is not 100% effective and will only help protect against the 13 strains included in the vaccine
Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1‐800‐822‐7967.
